Patents by Inventor Xizhen SONG

Xizhen SONG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250051301
    Abstract: Disclosed are a compound represented by formula (I) as a mutant isocitrate dehydrogenase 1 and 2 (IDH1 and IDH2) inhibitor, a preparation method therefor, and a pharmaceutical composition thereof. Also disclosed is a use of the described compound or the pharmaceutical composition thereof in the treatment of mutant IDH1 and IDH2-mediated diseases.
    Type: Application
    Filed: March 14, 2023
    Publication date: February 13, 2025
    Inventors: Yabin Li, Xiaofeng Xu, Xizhen Song, Jingwei Ding, Yunlai Zhang, Jie Chen, Xiangyong Liu, Lieming Ding, Jiabing Wang
  • Publication number: 20240246994
    Abstract: Disclosed are a polymorph of (S)-1-(2-((S)-3-cyclopropyl-5-isopropyl-2,4-dioxoimidazolidin-1-yl)-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepin-9-yl)pyrrolidine-2-carboxamide, a composition comprising the polymorph, a use method therefor and a preparation method therefor.
    Type: Application
    Filed: May 12, 2022
    Publication date: July 25, 2024
    Applicant: Betta Pharmaceuticals Co., Ltd.
    Inventors: Houxian ZU, Liang CHEN, Xizhen SONG, Xintao ZHAO, Kai CHEN, Xiaoyun LIU, Jin WANG, Zhifang XIA, Ying XU, Yuanzheng ZHOU, Lieming DING, Jiabing WANG
  • Publication number: 20230391779
    Abstract: The present invention relates to compounds of Formula (I), pharmaceutical compositions comprising such compounds and use thereof. The compounds are useful in treating, preventing or ameliorating diseases or disorders such as cancer.
    Type: Application
    Filed: August 17, 2021
    Publication date: December 7, 2023
    Applicant: Betta Pharmaceuticals Co., Ltd.
    Inventors: Xiaofeng XU, Jinheng GAO, Hongfei RONG, Xizhen SONG, Jie CHEN, Xiangyong LIU, Hongling SHEN, Jing GUO, Dan YAN, Hong LAN, Lieming DING, Jiabing WANG
  • Publication number: 20230053342
    Abstract: An imidazolidinone compound represented by formula (I), or a stereoisomer thereof, a geometric isomer thereof, or a tautomer thereof, or a pharmaceutically acceptable salt thereof, a pharmaceutical composition containing the compound, a synthesis method therefor and use thereof.
    Type: Application
    Filed: November 4, 2020
    Publication date: February 23, 2023
    Applicant: BETTA PHARMACEUTICALS CO., LTD
    Inventors: Houxian ZU, Xizhen SONG, Kai CHEN, Xiangyong LIU, Jie CHEN, Yajing BIAN, Lieming DING, Jiabing WANG